Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naive Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion

Objectives. To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO). Design, Setting, and Patients. Phase IV, prospective, open-label, single-arm trial in 11 Spanish hospitals. Treatment-...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ophthalmology 2018-01, Vol.2018
Main Authors: Cervera, Enrique, Crespi, Jaume, Manzanas, Lucia, Arias, Luis, Fonollosa, Alex, de Figueroa, Marta Suarez, Gallego, Roberto, Amparo, Navea, Gomez-Ulla, Francisco, Araiz, Javier, Donate, Juan, Garcia-Arumi, Jose
Format: Article
Language:English
Subjects:
Aflibercept
Bevacizumab
Clinical trials
Diabetic retinopathy
Edema
Hospitals
Labels
Pharmaceutical industry
Ranibizumab
Retinal diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives. To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO). Design, Setting, and Patients. Phase IV, prospective, open-label, single-arm trial in 11 Spanish hospitals. Treatment-naive patients with
ISSN:2090-004X